Literature DB >> 22158255

The prevalence of pulmonary embolism in chronically paralyzed subjects: a review of available evidence.

J H Frisbie1, G V R K Sharma.   

Abstract

STUDY
DESIGN: Qualitative systematic review.
OBJECTIVES: To examine the validity of the prevailing notion that pulmonary embolism (PE) is rare in the chronic spinal cord injury (SCI) population.
SETTING: USA.
METHODS: Review surveys of adult SCI subjects >2 months after injury in which PE has been looked for and its prevalence estimated.
RESULTS: A total of 16 surveys of chronic SCI subjects published between 1956 and 2009 offered data on PE prevalence. Two autopsy surveys, 178 subjects paralyzed >2 months, revealed no PE. Eleven surveys of the cause of death, 3193 subjects paralyzed 1-25 years, revealed PE in 2.1%. Two surveys of survivors of SCI, 5761 subjects paralyzed 1-25 years, revealed PE in 0.4%. Our survey of 112 subjects paralyzed 1-50 years before death, revealed PE in 21 (18.7%), based on autopsy, imaging, clinical and electrocardiographic evidence. In 7 (33%) of the 21 subjects with PE, pulmonary hypertension by transthoracic echocardiography was detected, indicating recurrent and/or unresolved PE.
CONCLUSION: PE is not infrequent in the chronic SCI subject; but its presentation may be subclinical; and its apparent recurrence may lead to pulmonary hypertension.

Entities:  

Mesh:

Year:  2011        PMID: 22158255     DOI: 10.1038/sc.2011.154

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  2 in total

1.  Incidence of pulmonary embolism after the first 3 months of spinal cord injury.

Authors:  S Alabed; L L de Heredia; A Naidoo; M Belci; R J Hughes; T M Meagher
Journal:  Spinal Cord       Date:  2015-06-23       Impact factor: 2.772

Review 2.  Thromboembolism in the Sub-Acute Phase of Spinal Cord Injury: A Systematic Review of the Literature.

Authors:  Samer Alabed; Maurizio Belci; Joost J Van Middendorp; Ahmed Al Halabi; Tom M Meagher
Journal:  Asian Spine J       Date:  2016-10-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.